In 2010, Ramos-Casals and colleagues reported that there had been 38 cases of sarcoidosis or “sarcoid like” granulomatous disease during anti-TNF-α therapy out of 1370 adult patients of systemic autoimmune diseases under the use of biological agents [9, 10]. This evidence concerns the gene TNF and sarcoidosis.